Alopecia News and Research

RSS
Alopecia is the lack or loss of hair from areas of the body where hair is usually found. Alopecia can be a side effect of some cancer treatments.
Taxotere (docetaxel) granted FDA approval to treat locally advanced head and neck cancer prior to chemo and surgery

Taxotere (docetaxel) granted FDA approval to treat locally advanced head and neck cancer prior to chemo and surgery

Bayer and Onyx submit supplemental NDA for Nexavar

Bayer and Onyx submit supplemental NDA for Nexavar

Mammals have the power to regenerate

Mammals have the power to regenerate

Understanding link between polycystic ovary syndrome and insulin resistance

Understanding link between polycystic ovary syndrome and insulin resistance

FDA approval for Gemzar for ovarian cancer

FDA approval for Gemzar for ovarian cancer

Finding opens new pathways for treating or preventing autoimmune diseases

Finding opens new pathways for treating or preventing autoimmune diseases

Bedsores and bald hides: novel roles revealed for a "scaffolding" protein

Bedsores and bald hides: novel roles revealed for a "scaffolding" protein

New research suggests it may be possible to separate the anticancer properties of vitamin D

New research suggests it may be possible to separate the anticancer properties of vitamin D

New radiation technique to treat cancer that has spread to the brain prevents hair loss

New radiation technique to treat cancer that has spread to the brain prevents hair loss

Approval for Temodar (temozolomide) capsules for newly diagnosed glioblastoma multiforme

Approval for Temodar (temozolomide) capsules for newly diagnosed glioblastoma multiforme

European approval for Taxotere (docetaxel) in prostate cancer

European approval for Taxotere (docetaxel) in prostate cancer

Hair cloning could be the cure for baldness

Hair cloning could be the cure for baldness

Treatment helps 26% of black Americans with chronic hepatitis C

Treatment helps 26% of black Americans with chronic hepatitis C

First drug approved for hormone refractory prostate cancer that has shown a survival benefit

First drug approved for hormone refractory prostate cancer that has shown a survival benefit